Literature DB >> 22250090

Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells.

Nourredine Himoudi1, Daniel A Morgenstern, Mengyong Yan, Bertrand Vernay, Luisa Saraiva, Yin Wu, Cyrille J Cohen, Kenth Gustafsson, John Anderson.   

Abstract

Activated human blood γδ T cells have also been previously demonstrated to behave as professional APCs, although the processes that control APC function have not been characterized. n this study, we show that the acquisition of potent APC function by human blood γδ T cells is achieved after physical interaction with an Ab-coated target cell, a process that we refer to as licensing. In cancer models, licensing of γδ T cells by tumor-reactive mAbs promotes the uptake of tumor Ags and professional presentation to tumor-reactive αβ T cells. We propose that licensing by Ab is a mechanism whereby the adaptive properties of γδ T cells are induced by their innate functions in a spatially and temporally controlled manner.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22250090     DOI: 10.4049/jimmunol.1102654

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

1.  Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab.

Authors:  Kilian Wistuba-Hamprecht; Alexander Martens; Karin Haehnel; Marnix Geukes Foppen; Jianda Yuan; Michael A Postow; Phillip Wong; Emanuela Romano; Amir Khammari; Brigitte Dreno; Mariaelena Capone; Paolo A Ascierto; Ilja Demuth; Elisabeth Steinhagen-Thiessen; Anis Larbi; Bastian Schilling; Dirk Schadendorf; Jedd D Wolchok; Christian U Blank; Graham Pawelec; Claus Garbe; Benjamin Weide
Journal:  Eur J Cancer       Date:  2016-07-09       Impact factor: 9.162

2.  Tumor-infiltrating γδT cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer.

Authors:  Jieti Wang; Chao Lin; He Li; Ruochen Li; Yifan Wu; Hao Liu; Heng Zhang; Hongyong He; Weijuan Zhang; Jiejie Xu
Journal:  Oncoimmunology       Date:  2017-07-24       Impact factor: 8.110

Review 3.  Combination strategies to enhance the potency of monocyte-derived dendritic cell-based cancer vaccines.

Authors:  Ronald J Fecek; Walter J Storkus
Journal:  Immunotherapy       Date:  2016-10       Impact factor: 4.196

Review 4.  Role of gamma-delta T-cells in cancer: another opening door to immunotherapy.

Authors:  Diego Marquez-Medina; Joel Salla-Fortuny; Antonieta Salud-Salvia
Journal:  Clin Transl Oncol       Date:  2012-10-02       Impact factor: 3.405

Review 5.  Six-of-the-best: unique contributions of γδ T cells to immunology.

Authors:  Pierre Vantourout; Adrian Hayday
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

6.  Human γδ T cells augment antigen presentation in Listeria Monocytogenes infection.

Authors:  Yuli Zhu; Huaishan Wang; Yi Xu; Yu Hu; Hui Chen; Lianxian Cui; Jianmin Zhang; Wei He
Journal:  Mol Med       Date:  2016-09-19       Impact factor: 6.354

7.  Mycobacterium-Specific γ9δ2 T Cells Mediate Both Pathogen-Inhibitory and CD40 Ligand-Dependent Antigen Presentation Effects Important for Tuberculosis Immunity.

Authors:  Getahun Abate; Charles T Spencer; Fahreta Hamzabegovic; Azra Blazevic; Mei Xia; Daniel F Hoft
Journal:  Infect Immun       Date:  2015-12-07       Impact factor: 3.441

8.  Frequent Malaria Drives Progressive Vδ2 T-Cell Loss, Dysfunction, and CD16 Up-regulation During Early Childhood.

Authors:  Lila A Farrington; Prasanna Jagannathan; Tara I McIntyre; Hilary M Vance; Katherine Bowen; Michelle J Boyle; Felistas Nankya; Samuel Wamala; Ann Auma; Mayimuna Nalubega; Esther Sikyomu; Kate Naluwu; Victor Bigira; James Kapisi; Grant Dorsey; Moses R Kamya; Margaret E Feeney
Journal:  J Infect Dis       Date:  2015-12-13       Impact factor: 5.226

9.  Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies.

Authors:  Drew C Deniger; Sourindra N Maiti; Tiejuan Mi; Kirsten C Switzer; Vijaya Ramachandran; Lenka V Hurton; Sonny Ang; Simon Olivares; Brian A Rabinovich; M Helen Huls; Dean A Lee; Robert C Bast; Richard E Champlin; Laurence J N Cooper
Journal:  Clin Cancer Res       Date:  2014-05-15       Impact factor: 12.531

Review 10.  γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer.

Authors:  Bruno Silva-Santos; Sofia Mensurado; Seth B Coffelt
Journal:  Nat Rev Cancer       Date:  2019-07       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.